Send us Feedback

Sangamo BioSciences (SGMO)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
QUOTE AND NEWS
Sangamo BioSciences Announces Presentations At Upcoming Investor Conferences
PR Newswire  May 7  Comment 
RICHMOND, Calif., May 7, 2012 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic® development programs and
Sangamo Biosciences, Inc. (SGMO) Posts Q1 Loss of 14c/Share
StreetInsider.com  May 2  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Sangamo+Biosciences%2C+Inc.+%28SGMO%29+Posts+Q1+Loss+of+14cShare/7396039.html for the full story.
Sangamo BioSciences Reports First Quarter 2012 Financial Results
PR Newswire  May 2  Comment 
RICHMOND, Calif., May 2, 2012 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) today reported first quarter 2012 financial results and accomplishments. For the first quarter ended March 31, 2012, Sangamo reported a consolidated net loss of
Sangamo BioSciences Nominates Saira Ramasastry To The Company's Board Of Directors
PR Newswire  Apr 30  Comment 
RICHMOND, Calif., April 30, 2012 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO), the leader in the development of novel zinc finger DNA-binding proteins (ZFPs) for therapeutic gene modification and regulation, announced today the nomination
Sangamo BioSciences Announces First Quarter 2012 Conference Call and Webcast
PR Newswire  Apr 25  Comment 
RICHMOND, Calif., April 25, 2012 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced that the company will release its first quarter 2012 financial results on Wednesday, May 2, 2012, after the market closes. The press release
Sangamo BioSciences Announces Presentation at the Future Leaders in the Biotech Industry Conference
PR Newswire  Apr 12  Comment 
RICHMOND, Calif., April 12, 2012 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic® development programs
Sangamo BioSciences (SGMO) Reports Publication of Preclinical ZFN Data
StreetInsider.com  Apr 2  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Sangamo+BioSciences+%28SGMO%29+Reports+Publication+of+Preclinical+ZFN+Data/7312454.html for the full story.
Sangamo BioSciences Announces Publication in Nature Medicine Demonstrating Use of ZFN Technology to Engineer Safer and More Effective Cancer Treatments
PR Newswire  Apr 2  Comment 
RICHMOND, Calif., April 2, 2012 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today the publication of a preclinical study demonstrating the use of zinc finger nucleases (ZFNs) to engineer safer and more potent cancer
Sangamo BioSciences Announces Presentation at Needham Healthcare Conference
PR Newswire  Mar 28  Comment 
RICHMOND, Calif., March 28, 2012 /PRNewswire/ --Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic® development programs and
Sangamo Presents New Clinical Data at CROI 2012 Demonstrating Persistent Positive Effects of ZFN Therapeutic® for "Functional Cure" of HIV/AIDS
Benzinga  Mar 8  Comment 
Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced that new data from its program to develop a 'functional cure' for HIV/AIDS were described in two presentations at the 19th Conference on Retroviruses and Opportunistic Infections (CROI), held in...




more ▼WIKI ANALYSIS
 The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.


 




References

Retrieved from "http://www.wikinvest.com/stock/Sangamo_BioSciences_(SGMO)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki